|1.||Buchwald, Stephen L: 2 articles (05/2008 - 09/2005)|
|2.||Hennessy, Edward J: 2 articles (05/2008 - 09/2005)|
|3.||Venema, Paul: 1 article (03/2009)|
|4.||Lubbersen, Yvette S: 1 article (03/2009)|
|5.||van der Linden, Erik: 1 article (03/2009)|
|6.||Kroes-Nijboer, Ardy: 1 article (03/2009)|
|7.||Su, Linhui Julie: 1 article (05/2008)|
|8.||Wang, Huan: 1 article (05/2008)|
|9.||Shorter, James: 1 article (05/2008)|
|10.||Ingram, Vernon M: 1 article (05/2008)|
|1.||Alzheimer Disease (Alzheimer's Disease)
05/20/2008 - "Yet 4,5-dianilinophthalimide (DAPH-1) reverses Abeta42 amyloidogenesis and neurotoxicity, which is associated with Alzheimer's disease. "
03/01/2009 - "The molecule 4,5-dianilinophthalimide was recently found to be an efficient compound in disaggregating amyloid fibrils involved in the Alzheimer's disease. "
09/02/2005 - "Synthesis of 4,5-dianilinophthalimide and related analogues for potential treatment of Alzheimer's disease via palladium-catalyzed amination."
|2.||Retinoblastoma (Glioblastoma, Retinal)
02/01/1999 - "The authors studied whether administration of exogenous TGF-alpha into the brain can protect neurons against ischemia in a model of permanent middle cerebral artery (MCA) occlusion in the rat, and whether any effect of TGF-alpha was mediated by EGFR by administering 4,5-dianilinophthalimide (DAPH), a protein-tyrosine kinase inhibitor with high selectivity for EGFR. "
|1.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|2.||Transforming Growth Factor alpha (TGF-alpha)
|3.||Tretinoin (Retinoic Acid)
|4.||Staphylococcal Protein A (A, Protein)
|5.||Platelet-Derived Growth Factor
|7.||Epidermal Growth Factor (EGF)
|8.||Amyloid (Amyloid Fibrils)